Towia A. Libermann
Harvard University Press, Beth Israel Deaconess Medical Center
Papers
2
Total Citations
50
H-Index
2
About
Towia A. Libermann is a leading figure in proteomics and biomarker discovery, with a career dedicated to advancing protein profiling technologies for clinical diagnostics. His major contributions center on the optimization and automation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS), a powerful tool for identifying disease-specific protein signatures in complex biological samples like serum. In his highly cited 2005 work (48 citations), Libermann systematically evaluated SELDI-TOF MS with reversed-phase protein arrays, demonstrating its potential to revolutionize diagnostic testing by enabling reliable, reproducible protein profiling. He further pioneered the development of robot-pipelined automation for SELDI-TOF MS, addressing the critical need for high-throughput, standardized workflows in proteomics. This automation work, though less cited, underscores his commitment to translating bench-top discoveries into scalable clinical applications. Libermann’s research has opened new avenues for non-invasive disease detection, positioning protein profiles as a transformative diagnostic tool. His achievements reflect a deep integration of analytical chemistry, bioinformatics, and clinical medicine, making him a key innovator in the quest for precision diagnostics through mass spectrometry-based proteomics.
Research Focus
Key Achievements
Top Papers
- 1
- 2Analysis and robot pipelined automation for SELDI-TOF mass spectrometry2 citations · 2005